Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Adamax Overview, Dosing & Safety | Peptide Database

Adamax Next-Generation Semax Derivative | Nootropic Neuropeptide Community Research Join others researching Adamax — share findings, ask questions, and learn from real experiences Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantan

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Adamax

Next-Generation Semax Derivative | Nootropic Neuropeptide

Community Research

Join others researching Adamax — share findings, ask questions, and learn from real experiences

Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement, neuroprotection, and neuroplasticity.

Crosses BBB via enhanced lipophilicity from adamantane; upregulates BDNF and TrkB receptor sensitivity; modulates dopamine, norepinephrine, and serotonin; stabilizes microtubules via ADNP-derived mechanisms; provides antioxidant and anti-inflammatory neuroprotection.

Molecular Data

Ac

Position 1

Methionine

Position 2

Glutamic Acid

Position 3

Histidine

Position 4

Phenylalanine

Position 5

Proline

Position 6

Glycine

Position 7

Position 8

AGly

Position 9

NH2

Position 10

Research Indications

Preliminary research suggests improvements in focus, mental clarity, memory consolidation, and complex task handling.

BDNF upregulation and TrkB enhancement promote new neural connections and synaptic plasticity for long-term improvements.

May enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.

Preliminary observations indicate improved neurological outcomes through oxidative stress reduction and neuronal repair.

Demonstrates antioxidant properties protecting against oxidative damage and inflammation-induced neuronal injury.

Supports neuronal survival and growth through BDNF enhancement and microtubule stabilization.

Influences serotonin and dopamine to elevate mood and reduce depressive symptoms through neurotransmitter modulation.

Anecdotal reports indicate reduced overwhelm and anxiety through balanced neurotransmitter activity.

HPA axis modulation may improve stress response and emotional well-being.

Dosing Protocols

Enhanced cognitive function and neuroprotection through direct systemic delivery with superior bioavailability.

Cognitive Enhancement

200-300mcg

1x daily

SubQ

Neuroprotection

300mcg

1-2x daily

Mood Support

200mcg

1x daily (morning)

Initial Trial

100-200mcg

Reconstitution Instructions

Bacteriostatic water (BAC)

Insulin syringes (0.5-1mL)

Alcohol swabs

Peptide vial

Sterile work surface

1 Clean work area and hands thoroughly with alcohol

2 Calculate required BAC water volume using calculator

3 Draw calculated BAC water into syringe

4 Inject slowly down vial side (not directly onto powder)

5 Gently swirl until completely dissolved (never shake vigorously)

6 Store reconstituted solution in refrigerator at 2-8°C

7 Use within 14-30 days for optimal potency

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Headaches (particularly at higher doses)

Insomnia or sleep disruption

Anxiety or overstimulation

Cardiovascular effects (elevated blood pressure, palpitations)

Stop Signs - Discontinue if:

Persistent or severe headaches

Chest pain, heart palpitations, or significant blood pressure increases

Severe anxiety, insomnia, or mood disturbances

Unusual neurological symptoms or mental status changes

Persistent injection site reactions or infection signs

Gastrointestinal distress (nausea, vomiting, diarrhea)

Contraindications

Pregnancy and breastfeeding

Cardiovascular conditions (without medical supervision)

Severe anxiety disorders

Uncontrolled hypertension

Quality Checklist

Good Signs

White, fluffy powder indicating proper freeze-drying

Clear solution after reconstitution with no particles or cloudiness

Proper labeling with peptide name, batch number, manufacturing date

Warning Signs

Slight compaction from shipping acceptable if powder dissolves completely

Bad Signs

Discoloration or yellowing indicates oxidation or degradation

Persistent cloudiness or particles indicate degradation or contamination

Frequently Asked Questions

How does Adamax improve cognition differently than Semax?

Adamax is a next-generation Semax derivative with C-terminal adamantane modification for enhanced lipophilicity and blood-brain barrier penetration. While parent Semax shows cognitive benefits, Adamax's superior stability and BBB crossing potentially enable stronger cognitive effects at lower doses and with more sustained action.

Can Adamax cause overstimulation if combined with other nootropics?

Yes. Adamax shares BDNF upregulation with compounds like Noopept, so combining them risks excessive neurotropic effects. Start with lower doses and monitor for overstimulation, anxiety, or sleep disruption. Safe stacking requires careful dose titration and might be better avoided for most users.

What causes the headaches some people report on Adamax?

Headaches are most common at higher doses (particularly above 300mcg). This likely relates to the potent dopamine, norepinephrine, and serotonin modulation combined with BDNF upregulation creating temporary neurochemical shifts. Starting at 100-200mcg and titrating slowly minimizes this risk.

How long do Adamax's cognitive effects last after stopping?

Due to BDNF-mediated neuroplasticity improvements, cognitive benefits persist weeks or months beyond discontinuation. Peak neuroprotective and structural brain benefits appear by week 4+ with continuous use, but the neuronal changes induced by BDNF upregulation have lasting effects independent of the compound remaining in circulation.

References

Foundational Semax review: intranasal doses stimulate operative memory and attention for 20-24 hours. Adamax builds on the Semax core sequence with adamantane modification for enhanced stability and BBB penetration.

Single application at 50 mcg/kg produced 1.4-fold increase in BDNF protein and 1.6-fold increase in trkB tyrosine phosphorylation in rat hippocampus, supporting Adamax's BDNF-TrkB mechanism.

110 ischemic stroke patients; Semax (6000 mcg/day intranasal) increased BDNF plasma levels and accelerated functional recovery, providing the clinical basis for Adamax neuroprotective applications.

Genome-wide analysis: Semax modulated 24 vascular genes at 3h and enhanced immune-response gene expression at 24h post-ischemia, demonstrating multi-pathway neuroprotection.

Related Peptides

Adamax is an enhanced derivative with improved stability and bioavailability.

Adamax incorporates adamantyl portion from P21; may complement cognitive benefits.

Different mechanisms—Adamax targets neurological function; BPC-157 focuses on tissue repair.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Frequently Asked Questions About Adamax

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

Source: peptidemind.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →